Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Paul A Northcott
Affiliation
St Jude Children's Research Hospital
ORCID
Career Start Year
2006
Papers
187
H Index
79
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36548930
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
J Clin Oncol
2023
37725078
Lmx1a is a master regulator of the cortical hem.
Elife
2023
37693484
PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression.
bioRxiv
2023
36548930
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
J Clin Oncol
2023
37693484
PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression.
bioRxiv
2023
37725078
Lmx1a is a master regulator of the cortical hem.
Elife
2023
34894262
Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.
Neuro Oncol
2022
35463474
Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients.
STAR Protoc
2022
35709750
Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.
Mol Cancer Ther
2022
35701672
Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Nat Genet
2022
35831316
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.
Nat Commun
2022
35618754
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.
Nat Commun
2022
36131015
Unified rhombic lip origins of group 3 and group 4 medulloblastoma.
Nature
2022
35982322
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Acta Neuropathol
2022
36052493
Pursuing FOXR2-Driven Oncogenesis.
Cancer Res
2022
34894262
Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.
Neuro Oncol
2022
34935967
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Neuro Oncol
2022
34934181
Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
Lab Invest
2022
35709750
Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.
Mol Cancer Ther
2022
35701672
Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Nat Genet
2022
35831316
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.
Nat Commun
2022
35463474
Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients.
STAR Protoc
2022
35618754
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.
Nat Commun
2022
36131015
Unified rhombic lip origins of group 3 and group 4 medulloblastoma.
Nature
2022
35982322
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Acta Neuropathol
2022
36052493
Pursuing FOXR2-Driven Oncogenesis.
Cancer Res
2022
34935967
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Neuro Oncol
2022
34934181
Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
Lab Invest
2022
33272592
Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond.
Trends Genet
2021
34292305
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.
JAMA Oncol
2021
34110925
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.
J Clin Oncol
2021
34215733
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.
Nat Commun
2021
34192534
Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Cell Rep
2021
33502920
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
J Clin Oncol
2021
33976373
Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth.
Commun Biol
2021
34320362
Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Cell Rep
2021
33272592
Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond.
Trends Genet
2021
33405951
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
J Clin Oncol
2021
34409497
Subgroup and subtype-specific outcomes in adult medulloblastoma.
Acta Neuropathol
2021
34678152
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Cancer Cell
2021
34647023
A genetic mouse model with postnatal <i>Nf1</i> and <i>p53</i> loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor.
Neurooncol Adv
2021
33502920
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
J Clin Oncol
2021
34647023
A genetic mouse model with postnatal <i>Nf1</i> and <i>p53</i> loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor.
Neurooncol Adv
2021
34409497
Subgroup and subtype-specific outcomes in adult medulloblastoma.
Acta Neuropathol
2021
34678152
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.
Cancer Cell
2021
34215733
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.
Nat Commun
2021
34320362
Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Cell Rep
2021
34292305
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.
JAMA Oncol
2021
33976373
Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth.
Commun Biol
2021
34192534
Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
Cell Rep
2021
1 - 50 of 374
Column Actions
Search
Recommended Authors
Xose S Puente
Universidad de Oviedo
Career Start Year
2019
Number of shared co-authors
51
Venu Thatikonda
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
2018
Number of shared co-authors
49
Selin Jessa
McGill University
Career Start Year
2017
Number of shared co-authors
26
Shannon Robins
Children's Hospital of Philadelphia
Career Start Year
2017
Number of shared co-authors
19
Katherine E Miller
College of Medicine, The Ohio State University
Career Start Year
2017
Number of shared co-authors
8
Sibo Zhao
Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine
Career Start Year
2016
Number of shared co-authors
9
Yuankun Zhu
Children's Hospital of Philadelphia
Career Start Year
2016
Number of shared co-authors
34
Kyle Juraschka
The Hospital for Sick Children, University of Toronto
Career Start Year
2014
Number of shared co-authors
60
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2014
Number of shared co-authors
21
Jennifer A Cotter
Children's Hospital Los Angeles
Career Start Year
2014
Number of shared co-authors
26
Jaime M Guidry Auvil
National Cancer Institute
Career Start Year
2013
Number of shared co-authors
24
Krutika S Gaonkar
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2012
Number of shared co-authors
19
Robert Siddaway
Hospital for Sick Children
Career Start Year
2011
Number of shared co-authors
21
David R Raleigh
University of California san francisco
Career Start Year
2010
Number of shared co-authors
27
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year
2010
Number of shared co-authors
50
Daniela S Gerhard
National Cancer Institute
Career Start Year
2009
Number of shared co-authors
25
Payal Jain
Maharaja Agrasen Medical College
Career Start Year
2009
Number of shared co-authors
28
Patricia Baxter
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year
2008
Number of shared co-authors
52
Ludivine Coudi??re Morrison
University of Manitoba
Career Start Year
2007
Number of shared co-authors
65
Matthew D Wood
Oregon Health & Science University
Career Start Year
2007
Number of shared co-authors
36
Roel G W Verhaak
Yale School of Medicine
Career Start Year
2004
Number of shared co-authors
49
Ga??lle Pierron
Institut Curie Hospital
Career Start Year
2001
Number of shared co-authors
22
Tamra E Werbowetski-Ogilvie
University of Manitoba
Career Start Year
2001
Number of shared co-authors
65
Xiang Chen
St. Jude Children's Research Hospital
Career Start Year
1999
Number of shared co-authors
33
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Career Start Year
1997
Number of shared co-authors
62
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year
1995
Number of shared co-authors
35
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1994
Number of shared co-authors
44
Javed Khan
Center for Cancer Research, National Cancer Institute
Career Start Year
1993
Number of shared co-authors
38
Joseph F Costello
University of California san francisco
Career Start Year
1991
Number of shared co-authors
51
Ching C Lau
Baylor College of Medicine
Career Start Year
1982
Number of shared co-authors
72
row(s) 1 - 30 of 30
Collaborators
Michael D Taylor
The Hospital for Sick Children
Co-authored papers
108
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
96
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
69
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
68
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
54
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers
48
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers
45
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers
37
James T Rutka
Hospital for Sick Children
Co-authored papers
32
Eric Bouffet
The Hospital for Sick Children
Co-authored papers
32
Giles W Robinson
St. Jude Children's Research Hospital
Co-authored papers
31
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers
31
Adrian M Dubuc
Dana-Farber Cancer Institute
Co-authored papers
29
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers
26
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Co-authored papers
25
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
25
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
24
David W Ellison
St. Jude Children's Research Hospital
Co-authored papers
24
David J H Shih
University of Texas MD Anderson Cancer Center Houston
Co-authored papers
24
Scott L Pomeroy
Harvard Medical School
Co-authored papers
24
Andreas von Deimling
Co-authored papers
24
Kyle S Smith
St. Jude Children's Research Hospital
Co-authored papers
22
William A Weiss
University of California san francisco
Co-authored papers
21
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers
21
Stephen C Mack
St Jude Children's Research Hospital
Co-authored papers
20
Hendrik Witt
Co-authored papers
20
Brent A Orr
St. Jude Children's Research Hospital
Co-authored papers
20
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
19
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
18
Marc Zapatka
Co-authored papers
18
1 - 30